Clinical trial
Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis
NCT01720238 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis
- Lead sponsor
- Beijing Friendship Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2012
- Completion date
- December 31, 2018
- Enrollment
- 621 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.